Granules Pharmaceuticals, Inc., a 100% foreign subsidiary of Granules India received the U.S. Food & Drug Administration (USFDA) approval for abbreviated new drug application (ANDA) of Bupropion hydrochloride extended-release tablets USP (SR).
Posts in category Business Standard
Maharashtra Scooters up 8% as it deemed fit for special-call auctions (18-10-2024)
Maharashtra Scooters has at least 90 per cent of its assets invested in Bajaj group companies
Wipro jumps on declaring 1:1 bonus issue (18-10-2024)
Wipro gained 4.05% to Rs 550.20 after the IT major recorded decent earnings for the second quarter of FY25 and announced a 1:1 bonus issue.
Zydus Life gets final approval from USFDA for Fludrocortisone Acetate tab (18-10-2024)
Zydus Lifesciences announced that it has received final approval from the United States Food and Drug Administration (USFDA) to manufacture Fludrocortisone Acetate tablets USP, 0.1 mg.
Board of Diamond Power Infrastructure appoints director (18-10-2024)
At meeting held on 18 October 2024
Net direct tax collections zoom around 180% over last decade on robust growth in personal income tax (18-10-2024)
India’s net direct tax collections jumped by 182.02% over last decade to Rs 19.60 lakh crore in FY24, from 6.95 lakh crore in FY15, following strong growth in personal income tax, the latest time series data from the Income Tax Department showed. Personal income tax collections zoomed up nearly 300% to Rs 10.45 lakh crore, from 2.65 lakh crore in FY15, outpacing corporate tax collections, which rose by 112.85% to Rs 9.11 lakh crore from Rs 4.28 lakh crore in FY15.
Granules India receives USFDA approval for Bupropion Hydrochloride ER Tablets USP (18-10-2024)
Granules India announced today that the U.S. Food & Drug Administration (USFDA) has approved the Abbreviated New Drug Application (ANDA) for Bupropion Hydrochloride Extended-Release Tablets USP (SR) 100 mg, 150 mg, and 200 mg filed by Granules Pharmaceuticals, Inc. (GPI), a wholly owned foreign subsidiary of the Company.
Infosys Q2 PAT rises 2% QoQ to Rs 6,506 cr; declares dividend of Rs 21/share (18-10-2024)
The IT major reported 2.2% rise in consolidated net profit to Rs 6,506 crore on a 4.25% increase in revenues to Rs 40,986 crore in Q2 FY25 over Q1 FY25.
Quick Heal slumps 10% after posting weak Q2 results; Net profit down 68% (18-10-2024)
Quick Heal reported a 67.8 per cent decline in consolidated net profit at Rs 4.15 crore
This recently listed stock has zoomed 98% against issue price in 2 weeks (18-10-2024)
Shares of Diffusion Engineers surged 12% to Rs 333.20 on the BSE in Friday’s intra-day trade, and have zoomed 98% against its issue price of Rs 168 per share.